The states with the highest rates of influenza, according to the Index, were Arizona, Texas, Kentucky, Mississippi and Tennessee.
CNBC is reporting that at Express Scripts’ annual client conference, the company announced that it would be looking to partner with retail pharmacies that best maintain patient health in an effort to reduce costs associated with diabetes.
RxCrossroads, a subsidiary of CVS Health, unveiled plans for significant expansion of its distribution center in Louisville, Ky., the Courier-Journal, a USA Today publication, reported Thursday. Acquired in 2005 by Omnicare and later in 2015 by CVS Health, RxCrossroads offers a portfolio of specialty distribution, pharmacy and patient support services. Anticipating a surge in customer demand, the company has laid out plans for an $11 million building, with $8.7 million in equipment and $600,000 in additional startup costs, the Courier-Journal reported. (Courier-Journal)
Biopharmaceutical company AbbVie on Thursday announced its planned acquisition of Stemcentrx and its late-stage potential treatment for small cell lung cancer, Rova-T.
Medicare plan comparison platform iMedicare on Thursday announced that in 2-15 it helped more than 250,000 patients save an average of $1,150 each on their expected Medicare Part D costs.
The donations were inspired by a 13-hour, nearly 600-mile overnight truck delivery to provide lifesaving treatment to a newborn at a Toronto hospital on Christmas Day, 2015.
Lupin on Thursday announced that it would be re-introducing its Methergine (methylergonovine maleate) tablets.
By implementing Ateb's Time My Meds, Pharmacy First members will witness significant, measurable impact on increasing prescription fills and improving quality measures.
On Tuesday, the FDA approved Aurobindo’s generic Exforge (amlodipine and valsartan) tablets, and on Wednesday gave its OK to the company’s generic Opana (oxymorphone HCl) and Pepcid AC (famotidine).